These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12153550)

  • 1. Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients.
    Schalkwijk CG; Chaturvedi N; Twaafhoven H; van Hinsbergh VW; Stehouwer CD;
    Eur J Clin Invest; 2002 Jul; 32(7):500-6. PubMed ID: 12153550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK; Chaturvedi N; Fuller J
    Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.
    Schalkwijk CG; Ligtvoet N; Twaalfhoven H; Jager A; Blaauwgeers HG; Schlingemann RO; Tarnow L; Parving HH; Stehouwer CD; van Hinsbergh VW
    Diabetes; 1999 Dec; 48(12):2446-53. PubMed ID: 10580435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.
    Chaturvedi N; Sjolie AK; Stephenson JM; Abrahamian H; Keipes M; Castellarin A; Rogulja-Pepeonik Z; Fuller JH
    Lancet; 1998 Jan; 351(9095):28-31. PubMed ID: 9433426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition.
    Chaturvedi N; Fuller JH; Pokras F; Rottiers R; Papazoglou N; Aiello LP;
    Diabet Med; 2001 Apr; 18(4):288-94. PubMed ID: 11437859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
    Lancet; 1997 Jun; 349(9068):1787-92. PubMed ID: 9269212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy.
    Lengyel Z; Vörös P; Tóth LK; Németh C; Kammerer L; Mihály M; Tornóci L; Rosivall L
    Wien Klin Wochenschr; 2004 Apr; 116(7-8):240-5. PubMed ID: 15143863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.
    Klein RL; Hunter SJ; Jenkins AJ; Zheng D; Semler AJ; Clore J; Garvey WT;
    Diabetes Care; 2003 May; 26(5):1439-48. PubMed ID: 12716802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes.
    Fried LF; Forrest KY; Ellis D; Chang Y; Silvers N; Orchard TJ
    J Diabetes Complications; 2001; 15(3):113-9. PubMed ID: 11358679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes.
    Le DS; Miles R; Savage PJ; Cornell E; Tracy RP; Knowler WC; Krakoff J
    Diabetes Res Clin Pract; 2008 Dec; 82(3):317-23. PubMed ID: 18922595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.
    Goa KL; Haria M; Wilde MI
    Drugs; 1997 Jun; 53(6):1081-105. PubMed ID: 9179532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy.
    Sørensen VB; Rossing P; Tarnow L; Parving H; Nørgaard T; Kastrup J
    Clin Sci (Lond); 1998 Dec; 95(6):709-17. PubMed ID: 9831696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.
    Penno G; Chaturvedi N; Talmud PJ; Cotroneo P; Manto A; Nannipieri M; Luong LA; Fuller JH
    Diabetes; 1998 Sep; 47(9):1507-11. PubMed ID: 9726242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated long-term glycated haemoglobin precedes proliferative retinopathy and nephropathy in type 1 (insulin-dependent) diabetic patients.
    Kullberg CE; Arnqvist HJ
    Diabetologia; 1993 Oct; 36(10):961-5. PubMed ID: 8243877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion.
    Stehouwer CD; Zellenrath P; Polak BC; Baarsma GS; Nauta JJ; Donker AJ; den Ottolander GJ
    Diabetologia; 1992 Jun; 35(6):555-9. PubMed ID: 1612229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
    Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH
    Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiological role of Amadori-glycated proteins in diabetic microangiopathy.
    Schalkwijk CG; Lieuw-a-Fa M; van Hinsbergh VW; Stehouwer CD
    Semin Vasc Med; 2002 May; 2(2):191-7. PubMed ID: 16222610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of nephropathy in type 1 diabetic patients with proliferative retinopathy: a 10-year follow-up study.
    Lövestam-Adrian M; Agardh E; Agardh CD
    Diabetes Res Clin Pract; 1998 Jan; 39(1):11-7. PubMed ID: 9597369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.